Advertisement
Research Article

Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis

  • Piero Olliaro mail,

    olliarop@who.int

    Affiliations: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland, Centre for Tropical Medicine and Vaccinology, Nuffield Department of Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom

    X
  • Michel Vaillant,

    Affiliation: Competence Centre for Methodology and Statistics, Centre de Recherche Public – Santé (CRP-Santé), Luxembourg, Grand Duchy of Luxembourg

    X
  • Byron Arana,

    Affiliation: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland

    X
  • Max Grogl,

    Affiliation: Walter Reed Army Institute of Research (WRAIR) Division of Experimental Therapeutics, Silver Spring, Maryland, United States of America

    X
  • Farrokh Modabber,

    Affiliation: Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland

    X
  • Alan Magill,

    Affiliation: Walter Reed Army Institute of Research (WRAIR) Division of Experimental Therapeutics, Silver Spring, Maryland, United States of America

    X
  • Olivier Lapujade,

    Affiliation: UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland

    X
  • Pierre Buffet,

    Affiliation: UMR945, University Pierre & Marie Curie, Paris, France & Department of Parasitology, Pitié-Salpêtrière Hospital, APHP, Paris, France

    X
  • Jorge Alvar

    Affiliation: World Health Organization, Neglected Tropical Diseases (WHO/NTD), Geneva, Switzerland

    X
  • Published: March 21, 2013
  • DOI: 10.1371/journal.pntd.0002130

About the Authors

Piero Olliaro, Byron Arana, Olivier Lapujade
UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland
Piero Olliaro
Centre for Tropical Medicine and Vaccinology, Nuffield Department of Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom
Michel Vaillant
Competence Centre for Methodology and Statistics, Centre de Recherche Public – Santé (CRP-Santé), Luxembourg, Grand Duchy of Luxembourg
Max Grogl, Alan Magill
Walter Reed Army Institute of Research (WRAIR) Division of Experimental Therapeutics, Silver Spring, Maryland, United States of America
Farrokh Modabber
Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland
Pierre Buffet
UMR945, University Pierre & Marie Curie, Paris, France & Department of Parasitology, Pitié-Salpêtrière Hospital, APHP, Paris, France
Jorge Alvar
World Health Organization, Neglected Tropical Diseases (WHO/NTD), Geneva, Switzerland

Corresponding Author

Email: olliarop@who.int

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: PO MV BA MG FM AM OL PB JA. Wrote the paper: PO MV BA MG FM AM OL PB JA.